We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

4 hedge funds and large institutions have $34.6M invested in Syneron Medical Ltd in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

85% less capital invested

Capital invested by funds: $235M → $34.6M (-$200M)

95% less funds holding

Funds holding: 79 → 4 (-75)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 73

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-75
Holders Change %
-94.94%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
2
Closed
73
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$25.7M
2
GLAM
Gardner Lewis Asset Management
Pennsylvania
-$17.4M
3
AA
AQR Arbitrage
Connecticut
-$16.2M
4
KPF
K2 Principal Fund
Ontario, Canada
-$12.1M
5
FTCM
First Trust Capital Management
Illinois
-$9.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIP
1
Brandes Investment Partners
California
$31.9M -$6.06M -553,126 -16%
LAM
2
Lapides Asset Management
Connecticut
$2.04M – – –
GLAM
3
Gardner Lewis Asset Management
Pennsylvania
$569K -$17.4M -1,586,096 -97%
AIM
4
Acrospire Investment Management
Illinois
$30K – – –
CCM
5
Camber Capital Management
Massachusetts
– -$25.7M -2,347,593 Closed
AA
6
AQR Arbitrage
Connecticut
– -$16.2M -1,479,055 Closed
KPF
7
K2 Principal Fund
Ontario, Canada
– -$12.1M -1,102,828 Closed
FTCM
8
First Trust Capital Management
Illinois
– -$9.64M -880,715 Closed
DGHMC
9
Dalton, Greiner, Hartman, Maher & Co
New York
– -$9.63M -879,740 Closed
MIFH
10
Migdal Insurance & Financial Holdings
Israel
– -$9.62M -878,350 Closed
Renaissance Technologies
11
Renaissance Technologies
New York
– -$6.36M -580,780 Closed
SG Americas Securities
12
SG Americas Securities
New York
– -$5.6M -511,420 Closed
COPPSERS
13
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$5.49M -501,440 Closed
MSU
14
Mizuho Securities USA
New York
– -$5.04M -460,000 Closed
CFIC
15
City Financial Investment Company
United Kingdom
– -$4.38M -399,948 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
– -$4.15M -378,695 Closed
State of Wisconsin Investment Board
17
State of Wisconsin Investment Board
Wisconsin
– -$3.5M -320,000 Closed
HA
18
Havens Advisors
New York
– -$3.07M -280,200 Closed
SMC
19
S. Muoio & Co
New York
– -$2.85M -260,000 Closed
KAM
20
Kassirer Asset Management
Ontario, Canada
– -$2.73M -248,819 Closed
JG
21
Jefferies Group
New York
– -$2.7M -246,800 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$2.36M -215,828 Closed
PIM
23
Profit Investment Management
Maryland
– -$2.36M -215,559 Closed
MWNA
24
Marshall Wace North America
New York
– -$2.3M -208,901 Closed
Ameriprise
25
Ameriprise
Minnesota
– -$2.28M -208,434 Closed
1
2 3 4

ELOS Hedge Fund Activity: Q3 2017 in Review

4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2017, worth a combined $34.6M — down 85% from $235M a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of ELOS and 0 opened new positions — a net loss of 73 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was Camber Capital Management, exiting entirely with an estimated $25.7M sold.

  • 4 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2017, down from 79 in Q2 2017.
  • Funds reported $34.6M of Syneron Medical Ltd stock for Q3 2017, down 85% quarter-over-quarter.
  • 0 funds opened new Syneron Medical Ltd positions in Q3 2017 and 73 closed out, a net change of -73 holders.
  • The largest Syneron Medical Ltd seller in Q3 2017 was Camber Capital Management, an estimated $25.7M sold.

Based on aggregated 13F filings for Q3 2017.